Sign In
Buy PNTG
The Pennant Group Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 54.25. In total, the insiders bought 750.51K and sold 16.59K PNTG shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
54.25 |
| ● Buy | 750.51K shares |
| ● Sell | 16.59K shares |
|
91% Buy Activity
Weak Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Aug 22, 2024 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $62.6K |
||
|
Aug 22, 2024 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $62.6K |
||
|
Aug 22, 2024 Buy |
Steik Jason Paul Chief Clinical Officer |
5 000 Value: $62.6K |
||
|
Feb 28, 2024 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
25 000 Value: $375.5K |
||
|
Feb 28, 2024 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
25 000 Value: $375.5K |
||
|
Feb 02, 2024 Buy |
Steik Jason Paul Chief Clinical Officer |
25 000 Value: $375.5K |
||
|
Jun 01, 2023 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
3 000 Value: $54.1K |
||
|
Jun 01, 2023 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
3 000 Value: $54.1K |
||
|
Oct 26, 2022 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
3 000 Value: $72.1K |
||
|
Oct 26, 2022 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
3 000 Value: $72.1K |
||
|
Oct 26, 2022 Buy |
Steik Jason Paul Chief Clinical Officer |
3 000 Value: $72.1K |
||
|
May 25, 2022 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $157.7K |
||
|
May 25, 2022 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $157.7K |
||
|
May 25, 2022 Buy |
Steik Jason Paul Chief Clinical Officer |
5 000 Value: $157.7K |
||
|
Feb 21, 2022 Buy |
Steik Jason Paul Chief Clinical Officer |
2 000 Value: $28.3K |
||
|
Oct 28, 2021 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $194.4K |
||
|
Oct 28, 2021 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $194.4K |
||
|
Oct 28, 2021 Buy |
Steik Jason Paul Chief Clinical Officer |
5 000 Value: $194.4K |
||
|
Aug 25, 2021 Buy |
Steik Jason Paul Chief Clinical Officer |
2 500 Value: $94.3K |
||
|
Aug 15, 2021 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
4 000 Value: $151.9K |
||
|
Aug 15, 2021 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
4 000 Value: $151.9K |
||
|
May 27, 2021 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $137.8K |
||
|
May 27, 2021 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
5 000 Value: $137.8K |
||
|
Oct 01, 2020 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
8 000 Value: $120.7K |
||
|
Oct 01, 2020 Buy |
Cheney Kirk Sterling EVP, GC And Corp Secy |
8 000 Value: $120.7K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
